Edition:
India

Cleveland Biolabs Q1 Loss Per Share $0.08 Excluding Items


Wednesday, 15 May 2019 

May 15 (Reuters) - Cleveland Biolabs Inc ::Q1 LOSS PER SHARE $0.08 EXCLUDING ITEMS.CLEVELAND BIOLABS-AS OF MARCH 31, 2019, HAD $3.3 MILLION IN CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS, IS EXPECTED TO FUND OPERATIONS INTO DEC 2019.REVENUE FOR Q1 OF 2019 DECREASED TO $0.20 MILLION COMPARED TO $0.23 MILLION FOR Q1 OF 2018. 

Company Quote

1.1
 --
19 Sep 2019